I’d buy this top UK stock now

The quality shines through from this FTSE 100 company and its brand has global appeal. Here’s why I’d buy the stock now for my long-term portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I like several things about global luxury goods manufacturer, retailer and wholesaler Burberry (LSE: BRBY).

For example, the company’s operating margin is running above 20%. And the balance sheet looks strong with only a modest level of net debt. I’m also impressed by the multi-year record of generally rising revenue, earnings, cash flow and shareholder dividends.

Overall, it’s hard for me to fault the quality indicators. However, I’m not the only investor who’s noticed the company’s attractions and the valuation looks full.

Expansion abroad and earnings growth

Following a hit from Covid-19, City analysts expect a strong rebound in earnings for the current trading year to March 2022. Then they’ve pencilled in further growth of around 14% for the following year. And with the share price near 2,251p, the forward-looking earnings multiple is just under 24. Meanwhile, the anticipated dividend yield is around 2.3%.

That’s pricey. And it’s always possible for those analysts to downgrade their estimates for earnings if the underlying business loses some of its operational momentum. So, although I’m seeing a quality enterprise, the valuation adds to the risk of me owning the stock.

However, the business and its British brand are making huge strides in expanding abroad. In the trading year to 27 March 2021, 52% of overall revenue came from the Asia Pacific region. And 27% came from Europe, the Middle East, India and Africa, with 21% originating in the Americas.

Chief executive Marco Gobbetti said in the full-year report that the company has “transformed” its business over the past three years. The brand is now “anchored” in luxury, with a “revitalised” brand image.

Looking ahead, the directors have their sights set on further growth. The aim is to drive the appeal of the brand with a relentless focus on quality. I think that’s a decent strategy in a world awash with cheap, low-quality merchandise. Much of the ‘junk’ we buy doesn’t last long and is often unfit for purpose. My guess is we’ll see a backlash against low quality in the years to come. And businesses such as Burberry could continue to do well.

Aiming for full-price sales

Along with the pursuit of quality, Burberry is also driving full-price sales rather than markdowns. And that makes a great deal of sense to me because a higher price is often a marker of quality. One example of a strategy based on that theme is the old ‘reassuringly expensive’ advertising campaign run by the Stella Artois brand over many years.

The directors reckon the adjusted operating margin will likely be under pressure in the current trading year to March 2022. The reasons for that are “operating expense normalisation” and increased investment to “accelerate” growth. However, in the years following, the company expects advances in the operating margin.

On balance, and although there are risks, I’d like to own this stock for the next 10 years or so. And I’d aim to buy some of the shares on dips and down-days, despite the pricey valuation.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended Burberry. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »